Is IMGO or JNJ a better dividend investment in 2026?

IMGO currently yields 5.55% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: IMGO offers higher current income.

What is the dividend yield difference between IMGO and JNJ?

IMGO has a forward dividend yield of 5.55% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2.19 percentage points.

Home › Compare › IMGO vs JNJ

IMGO vs JNJ: Dividend Comparison 2026

IMGO yields 5.55% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMGO wins by $8.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMGO

● Live price

5.55%

Share price

$36.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.8K

Annual income

$791.76

Full IMGO calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — IMGO vs JNJ

📍 IMGO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMGO	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMGO + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMGO pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMGO

Annual income on $10K today (after 15% tax)

$472.09/yr

After 10yr DRIP, annual income (after tax)

$673.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $30.62/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMGO + JNJ for your $10,000?

IMGO: 50%JNJ: 50%

100% JNJ50/50100% IMGO

Portfolio after 10yr

$24.4K

Annual income

$809.77/yr

Blended yield

3.31%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IMGO

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$36.00

-0.0% upside vs current

Range: $36.00 — $36.00

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMGO buys

JNJ buys

No recent congressional trades found for IMGO or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMGOJNJ

Forward yield	5.55% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$28.8K ✓	$20.0K
Annual income after 10y	$791.76	$827.78 ✓
Total dividends collected	$6.8K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy
Analyst price target	$36.00	$228.73 ✓

Year-by-year: IMGO vs JNJ ($10,000, DRIP)

Year	IMGO Portfolio	IMGO Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,255	$555.40	$10,676	$355.77	+$579.00 → IMGO
2	$12,628	$584.23	$11,407	$389.39	+$1.2K → IMGO
3	$14,124	$612.57	$12,198	$426.53	+$1.9K → IMGO
4	$15,753	$640.34	$13,056	$467.62	+$2.7K → IMGO
5	$17,523	$667.48	$13,987	$513.12	+$3.5K → IMGO
6	$19,444	$693.91	$14,998	$563.56	+$4.4K → IMGO
7	$21,524	$719.59	$16,098	$619.52	+$5.4K → IMGO
8	$23,776	$744.48	$17,295	$681.69	+$6.5K → IMGO
9	$26,208	$768.54	$18,599	$750.82	+$7.6K → IMGO
10	$28,835	$791.76	$20,022	$827.78	+$8.8K → IMGO

IMGO vs JNJ: Complete Analysis 2026

IMGO — Stock

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Full IMGO Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this IMGO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMGO vs SCHD IMGO vs JEPI IMGO vs O IMGO vs KO IMGO vs MAIN IMGO vs ABBV IMGO vs MRK IMGO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.